CHHE (China Health Industries Holdings) EBIT: $-2.80 Mil (TTM As of Mar. 2024)


CHHE China Health Industries Holdings Inc CHHE
20 GF Score
Price $0.00
View Full Analysis

What is China Health Industries Holdings EBIT?

China Health Industries Holdings CHHE 20 EBIT is $-2.80 Mil as of Mar. 2024. GuruFocus rates CHHE with a GF Score™ of 20/100.

China Health Industries Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-0.14 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-2.80 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. China Health Industries Holdings's annualized ROC % for the quarter that ended in Mar. 2024 was -5.77%. China Health Industries Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -19.19%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. China Health Industries Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -50.60%.

China Health Industries Holdings  (OTCPK:CHHE) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

China Health Industries Holdings's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-0.568 * ( 1 - 0% )/( (9.916 + 9.765)/ 2 )
=-0.568/9.8405
=-5.77 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4.265 - 0.655 - ( 0.015 - max(0, 6.555 - 0.249+0.015))
=9.916

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4.131 - 0.647 - ( 0.018 - max(0, 6.529 - 0.248+0.018))
=9.765

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

China Health Industries Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.572/( ( (3.043 + max(-0.675, 0)) + (2.918 + max(-0.764, 0)) )/ 2 )
=-0.572/( ( 3.043 + 2.918 )/ 2 )
=-0.572/2.9805
=-19.19 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.002 + 0.226) - (0.655 + 0.248 + -8.8817841970013E-16)
=-0.675

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0.002 + 0.225) - (0.647 + 0.344 + -8.8817841970013E-16)
=-0.764

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

China Health Industries Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-2.796/5.526
=-50.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Industries Holdings EBIT Related Terms

China Health Industries Holdings EBIT Historical Data

* Premium members only.

The historical data trend for China Health Industries Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Industries Holdings EBIT Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.69 5.02 2.02 -1.65 -1.84

China Health Industries Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 -2.03 -0.18 -0.45 -0.14

CHHE vs BIOE, CRYM, TXMD: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Industries Holdings EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's EV-to-EBIT falls into.


CHHE
20GF Score
China Health Industries Holdings Inc CHHE
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Industries Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-2.80 Mil mean?
China Health Industries Holdings (CHHE) has a EBIT of $-2.80 Mil as of Mar. 2024. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on China Health Industries Holdings.
Is China Health Industries Holdings' EBIT too high?
China Health Industries Holdings' current EBIT is $-2.80 Mil. Overall, China Health Industries Holdings has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does China Health Industries Holdings' EBIT compare to BIOE and CRYM?
China Health Industries Holdings' EBIT of $-2.80 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on China Health Industries Holdings. China Health Industries Holdings's current EBIT is $-2.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Industries Holdings stock overvalued right now?
China Health Industries Holdings (CHHE) has a current EBIT of $-2.80 Mil. The current EBIT is $-2.80 Mil. China Health Industries Holdings' overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For China Health Industries Holdings (CHHE), the current EBIT is $-2.80 Mil as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China Health Industries Holdings Business Description

Address 3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
20GF Score

Get the complete analysis for CHHE

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price